Adoptive immunotherapy following allogeneic bone marrow transplantation

Annual Review of Medicine

Volumn 49, Issue , 1998, Pages 329-340

  Dazzi, Francesco ^a   Goldman, John M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adoptive immunotherapy; Bone marrow transplantation; Cytomegalovirus; Donor lymphocyte infusion; Epstein Barr virus

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN RECOGNITION; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; NEOPLASM RECURRENCE, LOCAL; OPPORTUNISTIC INFECTIONS; REMISSION INDUCTION; RISK FACTORS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031968112     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.49.1.329     Document Type: Review

References (5)

1. Monaco JJ. 1992. A molecular model of NMC class-I-restricted antigen processing. Immunol. Today 13:173-79
2. Neefjes JJ, Ploegh HL. 1992. Intracellular transport of MHC class II molecules. Immunol. Today 13:179
3. Borysiewicz LK, Sissons JGO. 1986. Immunobiology of CMV infection. Immunol. Today 7:57-61
4. Meyers JD, Flournoy N, Thomas ED. 1986. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153:478-88
5. Quinnan GV, Kirmani N, Rook AH, et al. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-Iymphocyte cytotoxic response correlate with recovery from cytomegalovirus infection in bone-marrowtransplant recipients. N. Engl. J. Med. 307:7-13